The landscape of rare diseases presents both significant challenges and lucrative opportunities for pharmaceutical companies. With an estimated 7,000 rare diseases affecting millions of people worldwide, the demand for new treatments and therapies has never been higher. However, the complex nature of rare diseases, coupled with regulatory hurdles and market access barriers, requires...